Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin AS Chauhan, S Sridevi, KB Chalasani, AK Jain, SK Jain, NK Jain, ... Journal of controlled release 90 (3), 335-343, 2003 | 471 | 2003 |
Dendrimers for drug delivery AS Chauhan Molecules 23 (4), 938, 2018 | 352 | 2018 |
Poly (amidoamine)(PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient A Asthana, AS Chauhan, PV Diwan, NK Jain Aaps Pharmscitech 6, E536-E542, 2005 | 254 | 2005 |
Plants having potential antidiabetic activity: a review A Chauhan, PK Sharma, P Srivastava, N Kumar, R Dudhe Der Pharmacia Lettre 2 (3), 369-387, 2010 | 252 | 2010 |
Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats AS Chauhan, NK Jain, PV Diwan, AJ Khopade Journal of drug targeting 12 (9-10), 575-583, 2004 | 206 | 2004 |
Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly (amidoamine) dendrimers AS Chauhan, PV Diwan, NK Jain, DA Tomalia Biomacromolecules 10 (5), 1195-1202, 2009 | 202 | 2009 |
Dendritic polymers with enhanced amplification and interior functionality DA Tomalia, DR Swanson, B Huang, VR Pulgam, JR Heinzelmann, ... US Patent 7,985,424, 2011 | 175 | 2011 |
Dendrimers for enhanced drug solubilization S Svenson, AS Chauhan Future Medicine Ltd 3 (5), 679-702, 2008 | 170 | 2008 |
Performance evaluation of PAMAM dendrimer based simvastatin formulations H Kulhari, D Pooja, SK Prajapati, AS Chauhan International journal of pharmaceutics 405 (1-2), 203-209, 2011 | 109 | 2011 |
Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer YK Katare, RP Daya, C Sookram Gray, RE Luckham, J Bhandari, ... Molecular pharmaceutics 12 (9), 3380-3388, 2015 | 105 | 2015 |
Development of a topical resveratrol formulation for commercial applications using dendrimer nanotechnology T Pentek, E Newenhouse, B O’Brien, AS Chauhan Molecules 22 (1), 137, 2017 | 104 | 2017 |
Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice AS Chauhan, NK Jain, PV Diwan Proceedings of the Royal Society A: Mathematical, Physical and Engineering …, 2010 | 76 | 2010 |
Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics RK Tekade, M Tekade, M Kumar, AS Chauhan Pharmaceutical research 32, 910-928, 2015 | 68 | 2015 |
Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol AS Chauhan Annals of the New York Academy of Sciences 1348 (1), 134-140, 2015 | 64 | 2015 |
Optimization of carboxylate-terminated poly (amidoamine) dendrimer-mediated cisplatin formulation H Kulhari, D Pooja, MK Singh, AS Chauhan Drug Development and Industrial Pharmacy 41 (2), 232-238, 2015 | 58 | 2015 |
Pharmacokinetic and pharmacodynamic studies of poly (amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia H Kulhari, DP Kulhari, SK Prajapati, AS Chauhan Molecular Pharmaceutics 10 (7), 2528-2533, 2013 | 52 | 2013 |
Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the controlled drug delivery: an acyclovir model formulation SK Yandrapu, P Kanujia, KB Chalasani, L Mangamoori, RV Kolapalli, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (4), 514-522, 2013 | 48 | 2013 |
Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents A Chauhan, P Diwan, N Jain, K Raghavan US Patent App. 10/103,137, 2003 | 47 | 2003 |
Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide MK Singh, D Pooja, H Kulhari, SK Jain, R Sistla, AS Chauhan European Journal of Pharmaceutical Sciences 96, 84-92, 2017 | 45 | 2017 |
Pharmaceutical applications of dendrimers AS Chauhan, H Kulhari Elsevier, 2019 | 35 | 2019 |